RA Capital Nexus Fund II, Director: Dice Therapeutics DICE Buy · Filed 23/03/27

Trade details

Type: Insider buy
Amount: $4,153,107.36
Shares · price: 151,132 sh · $27.48 a share
Held after: 6,561,060 sh
Stock: Dice Therapeutics DICE
Person: RA Capital Nexus Fund IIDirector
Trade date: 23/03/27
Filed: 23/03/27
Days to filing: 0 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +2.4%

Dice Therapeutics trades, last 26 weeks

What else happened in Dice Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/25~23/04/26

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06

RA Capital Nexus Fund II, Director — bought $4.2M of Dice Therapeutics DICE · 151,132 sh @ $27.48 | Whalegun